| Tyzeka (telbivudine) / Novartis |
NCT01260610: Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients |
|
|
| Withdrawn | N/A | 0 | RoW | Tenofovir, Telbivudine, Tenofovir plus Telbivudine | Institute of Liver and Biliary Sciences, India | Chronic Hepatitis B | 06/11 | 06/11 | | |
ChiCTR-OCC-12001987: The effects of telbivudine treatment on circulating Tregs and its significance in CHB patients |
|
|
| Completed | N/A | 41 | | none ;telbivudine | Institute for Infectious Diseases, Southwest Hospital, Third Military Medical University; The State Nuture Science Foundation, China, From the national scientific research project | Hepatitis B | | | | |
NCT01480492: Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection |
|
|
| Completed | N/A | 56 | RoW | Telbivudine | Cz Li | HBeAg Positive Chronic Hepatitis B Infection | 10/11 | 10/11 | | |
NCT01083251: The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection |
|
|
| Unknown status | N/A | 120 | RoW | Peginterferon + Vitamin D, Peginterferon, Sebivo, entecavir+ vitamin d | Ziv Hospital | Hepatitis B Virus | 02/12 | 12/12 | | |
NCT01958229: Efficacy Study of Telbivudine in Chronic Hepatitis B Patients |
|
|
| Completed | N/A | 23 | RoW | | National Taiwan University Hospital | Chronic Hepatitis B, Roadmap Concept in Chronic Hepatitis B Treatment, 24-week PCR Negativity of Telbivudine, PCR Negativity at 52 and 104 Week, HBeAg Seroconversion Rate at 52 and 104 Week | 03/12 | 04/13 | | |
NCT01732224: To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B |
|
|
| Completed | N/A | 69 | RoW | Tenofovir + Telbivudine, Tenofovir | Institute of Liver and Biliary Sciences, India | Spontaneous Reactivation of Hepatitis B | 04/14 | 04/14 | | |
NCT02049736: Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases |
|
|
| Withdrawn | N/A | 0 | RoW | Telbivudine | Chinese University of Hong Kong | Chronic Hepatitis B | 06/15 | 06/15 | | |
| Completed | N/A | 160 | RoW | Telbivudine, Sebivo | Chang Gung Memorial Hospital | Chronic Hepatitis B | 01/16 | 01/16 | | |
NCT02301650: The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children |
|
|
| Unknown status | N/A | 400 | NA | Lamivudine, 3-TC, CAS: 134678-17-4, Telbivudine, CAS: 3424-98-4, Tenofovir, Tenofovir Disoprox, CAS: 147127-20-6 | Beijing Ditan Hospital | the Safety of Anti-viral Drugs Used in Late Pregnancy | 10/17 | 12/17 | | |
NCT00051090: Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV |
|
|
| Withdrawn | N/A | 0 | NA | Telbivudine, Lamivudine, Efavirenz, Didanosine, Abacavir | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections, Hepatitis B | | | | |
